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In patients with lung cancer (LC), co-morbid conditions and 
symptoms complicate treatment, diminish quality of life 
and shorten survival1. Mental health symptoms are 
correlated with increased physical symptoms and decreases 
in survival2. We aimed to describe the burden of common 
symptoms and comorbidities characterized by use of 
diagnostic codes in older adults with LC receiving Medicare-
related healthcare. Based on the literature, we 
hypothesized increased rates of pain and mental health 
diagnoses in older adults with LC.
A total of 18073 patients with LC were identified among 
1,478,670 beneficiaries. We compared all ICD-10 coded 
diagnoses for patients with and without LC (comparison). 
Limiting our analysis for frequently coded ICD-10 diagnoses, 
we identified 651 codes utilized for older adults with lung 
cancer. Period prevalence and risk ratios were calculated for 
38 symptoms, along with 18 major co-morbidities, all as 
represented by single ICD-10 codes in this pilot study. Rates 
were unadjusted for this representative national sample.
The study population consisted of adults age 65 and over in 
the 2017 5% sample of Medicare carrier file data, a 
standard analytical file. A total of 18073 older adults with 
lung cancer were identified among 1,478,670 beneficiaries.
Gender Differences
An almost two-fold risk of anxiety (1.96; 1.90-
2.74) in Men. Body mass index below 19.9 
kg/m2  greater risk in Men (4.68; 4.57-6.45) 
than women (2.62; 3.37-2.54).
Compared to those without a history of LC, 
those with LC had increased rates of 
Depression, Anxiety, Pain, COPD, Liver Disease, 
Kidney Disease, Heart Disease/Failure, 
Weakness, Nausea/Vomiting, Weight Loss, 
Fatigue, Cough, Shortness of Breath.
Patients with a LC history are more frequently diagnosed with 
pain, mental health disorders, and other comorbid conditions 
than their peers without LC; these diagnoses may affect long-
term outcomes. Limitations of the study include the 
retrospective, cross-sectional nature of this large-scale 
clinical data. The data captures any recipient with a LC 
diagnosis in 2017, but lacks details on time since diagnosis, 
type of LC, stage, or treatment provided and are not adjusted 
for mortality. 
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Many of the findings, particularly the elevated rates of pain, 
depression, anxiety, lung and cardiovascular co-morbidities 
are consistent with the findings of existing literature.1,2
Future analysis of Medicare D and SEER-Medicare data may 
discern the impact of LC features (pathology, stage, adjuvant 
treatment) combined with comorbidity prevalence (pain, 
anxiety/depression, cardiovascular disease) on quality of life 
and mortality.
References
Funding
